Fetal Monitoring Market to Reach $5.2 Billion by 2027

-

The global fetal monitoring market is projected to reach $5.2 billion by 2027, growing at a CAGR of 7.3% from 2022 to 2027. The growth of the market is driven by the rising incidence of preterm births and maternal age, increasing demand for minimally invasive procedures, and technological advancements in fetal monitoring devices.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35700261

Key Market Drivers

> Rising incidence of preterm births and maternal age: The incidence of preterm births is increasing worldwide, due to factors such as increasing maternal age, obesity, and chronic diseases. Preterm births are associated with a number of complications, including respiratory distress syndrome, necrotizing enterocolitis, and intraventricular hemorrhage. Fetal monitoring can help to identify babies who are at risk of preterm birth and provide early intervention to improve outcomes.
> Increasing demand for minimally invasive procedures: Fetal monitoring devices are becoming increasingly minimally invasive, which is driving demand for these devices. Minimally invasive procedures are associated with a number of benefits, including reduced pain, shorter recovery time, and lower risk of infection.
> Technological advancements in fetal monitoring devices: Technological advancements in fetal monitoring devices are also driving the growth of the market. Newer devices offer a number of advantages over traditional devices, such as the ability to monitor the fetus for longer periods of time, the ability to transmit data wirelessly, and the ability to store and analyze data.

Segmentation

The global fetal monitoring market is segmented by product, method, application, portability, end user, and region.

> By product: The market is segmented into ultrasound, fetal monitors, telemetry devices, and fetal electrodes. Ultrasound is the most widely used product in the fetal monitoring market.
> By method: The market is segmented into invasive and non-invasive methods. Invasive methods involve the placement of a sensor inside the uterus, while non-invasive methods involve the use of external sensors.
> By application: The market is segmented into antepartum and intrapartum applications. Antepartum applications are used to monitor the fetus before labor, while intrapartum applications are used to monitor the fetus during labor.
> By portability: The market is segmented into portable and non-portable devices. Portable devices are more convenient for patients and healthcare providers, and they are therefore becoming increasingly popular.
> By end user: The market is segmented into hospitals, home healthcare settings, and ambulatory settings. Hospitals are the major end users of fetal monitoring devices.
> By region: The market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest market for fetal monitoring devices, followed by Europe and Asia Pacific.

Key Players

Some of the key players in the global fetal monitoring market include GE Healthcare, Philips Healthcare, Medtronic, Analogic Corporation, Corometrics, Masimo Corporation, Spacelabs Healthcare, Welch Allyn, and Fukuda Denshi.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=35700261

Future Outlook

The global fetal monitoring market is expected to continue to grow in the coming years, driven by the factors mentioned above. The market is expected to be dominated by the North American region, followed by Europe and Asia Pacific. Technological advancements in fetal monitoring devices are expected to provide new growth opportunities for the market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more